Huntington National Bank’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68 | Hold |
1
| – | – | ﹤0.01% | 2733 |
|
|
2025
Q4 | $68 | Hold |
1
| – | – | ﹤0.01% | 2661 |
|
|
2025
Q3 | $68 | Hold |
1
| – | – | ﹤0.01% | 2746 |
|
|
2025
Q2 | $68 | Hold |
1
| – | – | ﹤0.01% | 2791 |
|
|
2025
Q1 | $68 | Hold |
1
| – | – | ﹤0.01% | 2821 |
|
|
2024
Q4 | $68 | Hold |
1
| – | – | ﹤0.01% | 2849 |
|
|
2024
Q3 | $68 | Hold |
1
| – | – | ﹤0.01% | 2844 |
|
|
2024
Q2 | $68 | Hold |
1
| – | – | ﹤0.01% | 2809 |
|
|
2024
Q1 | $68 | Hold |
1
| – | – | ﹤0.01% | 2636 |
|
|
2023
Q4 | $68 | Hold |
1
| – | – | ﹤0.01% | 2543 |
|
|
2023
Q3 | $68 | Hold |
1
| – | – | ﹤0.01% | 2521 |
|
|
2023
Q2 | $68 | Hold |
1
| – | – | ﹤0.01% | 2490 |
|
|
2023
Q1 | $68 | Hold |
1
| – | – | ﹤0.01% | 2330 |
|
|
2022
Q4 | $68 | Sell |
1
-223
| -100% | -$15.3K | ﹤0.01% | 2189 |
|
|
2022
Q3 | $15K | Sell |
224
-1,562
| -87% | -$86.1K | ﹤0.01% | 1415 |
|
|
2022
Q2 | $57K | Buy |
1,786
+528
| +42% | +$15.5K | ﹤0.01% | 951 |
|
|
2022
Q1 | $44K | Buy |
1,258
+351
| +39% | +$10.5K | ﹤0.01% | 1104 |
|
|
2021
Q4 | $27K | Buy |
907
+906
| +90,600% | +$28.1K | ﹤0.01% | 1275 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2128 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2016 |
|
|
2021
Q1 | $0 | Sell |
1
-101
| -99% | -$4.64K | ﹤0.01% | 1911 |
|
|
2020
Q4 | $4K | Buy |
102
+101
| +10,100% | +$4.98K | ﹤0.01% | 1448 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1832 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1837 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1936 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1949 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1856 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | +$57 | ﹤0.01% | 1884 |
|
Huntington National Bank's GBT Position: Q1 2026 in Review
Huntington National Bank held its Global Blood Therapeutics, Inc. (GBT) position steady in Q1 2026 at 1 share worth $68. The position accounts for ﹤0.01% of the portfolio, ranked #2733.
Huntington National Bank first reported a position in GBT in Q2 2019 and has held it in 28 quarters since. The position peaked at $57K in Q2 2022. 1 fund tracked by Wall St. Rank holds GBT as of Q1 2026.
- Huntington National Bank held 1 share of Global Blood Therapeutics, Inc. worth $68 as of Q1 2026.
- Huntington National Bank left its Global Blood Therapeutics, Inc. share count unchanged in Q1 2026.
- Global Blood Therapeutics, Inc. made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2733 holding.
- Huntington National Bank first reported a position in Global Blood Therapeutics, Inc. in Q2 2019 and has held it in 28 quarters since.
- Huntington National Bank's Global Blood Therapeutics, Inc. position peaked at $57K in Q2 2022.
- 1 fund tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.